275 related articles for article (PubMed ID: 7196039)
1. Central action of phenylethylamine in rats.
Jagiełło-Wójtowicz E
Pol J Pharmacol Pharm; 1981; 33(1):59-71. PubMed ID: 7196039
[TBL] [Abstract][Full Text] [Related]
2. Central action of adrenaline.
Jagiełło-Wójtowicz E
Acta Physiol Pol; 1981; 32(2):169-80. PubMed ID: 7196677
[TBL] [Abstract][Full Text] [Related]
3. The effect of alpha-adrenolytics on central action of agonists and antagonists of dopaminergic system.
Zebrowska-Lupina I
Pol J Pharmacol Pharm; 1977; 29(4):393-404. PubMed ID: 20609
[TBL] [Abstract][Full Text] [Related]
4. Influence of fibrinogen degradation products on the action of amphetamine in the central nervous system.
Zwoliński J; Buczko W
Pol J Pharmacol Pharm; 1977; 29(3):313-9. PubMed ID: 560684
[TBL] [Abstract][Full Text] [Related]
5. Comparison of central effects of noradrenaline and dopamine injected into the lateral brain ventricle in rats.
Zebrowska-Lupina I; Malec D; Kleinrok Z
Acta Physiol Pol; 1975; 26(3):261-74. PubMed ID: 1242288
[TBL] [Abstract][Full Text] [Related]
6. Central action of glaucine in rodents.
Jagiełło-Wójtowicz E; Kleinrok Z; Jusiak L; Matuszek B; Daniłoś J; Chodakowska A
Acta Pol Pharm; 1994; 51(2):179-84. PubMed ID: 7863789
[TBL] [Abstract][Full Text] [Related]
7. Preliminary investigation on the central action of prostacyclin (PGI2) in rats.
Rajtar G; Kolasa K; Kleinrok Z
Pol J Pharmacol Pharm; 1981; 33(6):627-32. PubMed ID: 6752913
[TBL] [Abstract][Full Text] [Related]
8. Studies on the participation of the dopaminergic system in the central effects of chronically administered antidepressant drugs.
Kozyrska C; Zebrowska-Lupina I
Pol J Pharmacol Pharm; 1983; 35(2):115-26. PubMed ID: 6684769
[TBL] [Abstract][Full Text] [Related]
9. Central antiserotonergic and antidopaminergic action of pirenperone, a putative 5-HT2 receptor antagonist.
Pawłowski L; Siwanowicz J; Bigajska K; Przegaliński E
Pol J Pharmacol Pharm; 1985; 37(2):179-96. PubMed ID: 4048012
[TBL] [Abstract][Full Text] [Related]
10. Participation of prostaglandins E2 and F2 alpha in the action of fibrinopeptides A and B on the central dopaminergic system.
Swiderska D; Buczko W; Wiśniewski K
Pol J Pharmacol Pharm; 1986; 38(1):29-39. PubMed ID: 3463941
[TBL] [Abstract][Full Text] [Related]
11. The involvement of serotonin in the mechanism of central action of apomorphine.
Grabowska M
Pol J Pharmacol Pharm; 1976; 28(4):389-94. PubMed ID: 790347
[TBL] [Abstract][Full Text] [Related]
12. Central action of narcotic analgesics. I. Catalepsy and stereotypy in rats and narcotic analgesics.
Malec D; Fidecka S; Langwiński R
Pol J Pharmacol Pharm; 1977; 29(3):177-93. PubMed ID: 560683
[TBL] [Abstract][Full Text] [Related]
13. Interactions between agents stimulating and inhibiting the central dopamine receptors and octopamine.
Jagiełło-Wójtowicz
Acta Physiol Pol; 1980; 31(2):153-8. PubMed ID: 6771963
[TBL] [Abstract][Full Text] [Related]
14. The effect of bradykinin on central dopamine receptors.
Przesmycki K; Kleinrok Z
Pol J Pharmacol Pharm; 1976; 28(6):673-8. PubMed ID: 1034925
[TBL] [Abstract][Full Text] [Related]
15. Action of fibrinopeptides A and B on the central dopaminergic system of rats pretreated with indomethacin.
Swiderska D; Buczko W; Wiśniewski K
Pol J Pharmacol Pharm; 1986; 38(1):21-8. PubMed ID: 3763484
[TBL] [Abstract][Full Text] [Related]
16. Studies on the participation of the dopaminergic system in the central effects of chelidonine.
Kleinrok Z; Szponar J; Matuszek B; Jagiełło-Wójtowicz E
Pol J Pharmacol Pharm; 1990; 42(5):417-24. PubMed ID: 2098751
[TBL] [Abstract][Full Text] [Related]
17. The influence of insulin hypoglycemia on central dopaminergic structures of the rat.
Kleinrok Z; Ossowska G; Stelmasiak M; Juszkiewicz M
Pol J Pharmacol Pharm; 1983; 35(6):489-95. PubMed ID: 6377282
[TBL] [Abstract][Full Text] [Related]
18. Interaction of fibrinopeptides A and B with dopaminergic receptors in central nervous system.
Wawrzyniuk I; Buczko W; Wiśniewski K
Pol J Pharmacol Pharm; 1979; 31(4):365-72. PubMed ID: 574959
[TBL] [Abstract][Full Text] [Related]
19. Psychopharmacological profile of mesterolone.
Baran L; Przegaliński E
Pol J Pharmacol Pharm; 1981 Oct; 33(3):299-303. PubMed ID: 7198778
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of central action of octopamine.
Jagiełło-Wójtowicz E
Pol J Pharmacol Pharm; 1979; 31(5):509-16. PubMed ID: 121158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
